Report Detail
Global Diabetes Telemedicine Technology Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4719311 |
- 29 June, 2026 |
- Global |
- 105 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Diabetes Telemedicine Technology market size was valued at US$ 15610 million in 2025 and is forecast to a readjusted size of US$ 32030 million by 2032 with a CAGR of 10.9% during review period.
Diabetes telemedicine technology refers to the real-time monitoring, management and support of blood glucose levels of diabetic patients through remote communication and digital health tools. These technologies allow patients to stay in touch with health care professionals, no matter where they are, to adjust treatment plans in time, and to optimize glycemic control, thereby improving the convenience and effectiveness of diabetes management.
This report is a detailed and comprehensive analysis for global Diabetes Telemedicine Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Diabetes Telemedicine Technology market size and forecasts, in consumption value ($ Million), 2021-2032
Global Diabetes Telemedicine Technology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Diabetes Telemedicine Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Diabetes Telemedicine Technology market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetes Telemedicine Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetes Telemedicine Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Dexcom, Abbott Diabetes Care, Eli Lilly, Glooko, Insulet, Sanofi, Roche, 9amHealth, Philip, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Diabetes Telemedicine Technology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Diabetes Self-management
Diabetes Education
Others
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Medtronic
Dexcom
Abbott Diabetes Care
Eli Lilly
Glooko
Insulet
Sanofi
Roche
9amHealth
Philip
Eversense
American Diabetes Association
ADCES
HealthPartners
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetes Telemedicine Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetes Telemedicine Technology, with revenue, gross margin, and global market share of Diabetes Telemedicine Technology from 2021 to 2026.
Chapter 3, the Diabetes Telemedicine Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Diabetes Telemedicine Technology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetes Telemedicine Technology.
Chapter 13, to describe Diabetes Telemedicine Technology research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Diabetes Telemedicine Technology by Type
- 1.3.1 Overview: Global Diabetes Telemedicine Technology Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Diabetes Telemedicine Technology Consumption Value Market Share by Type in 2025
- 1.3.3 Diabetes Self-management
- 1.3.4 Diabetes Education
- 1.3.5 Others
- 1.4 Global Diabetes Telemedicine Technology Market by Application
- 1.4.1 Overview: Global Diabetes Telemedicine Technology Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Diabetes Telemedicine Technology Market Size & Forecast
- 1.6 Global Diabetes Telemedicine Technology Market Size and Forecast by Region
- 1.6.1 Global Diabetes Telemedicine Technology Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Diabetes Telemedicine Technology Market Size by Region, (2021-2032)
- 1.6.3 North America Diabetes Telemedicine Technology Market Size and Prospect (2021-2032)
- 1.6.4 Europe Diabetes Telemedicine Technology Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Diabetes Telemedicine Technology Market Size and Prospect (2021-2032)
- 1.6.6 South America Diabetes Telemedicine Technology Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Diabetes Telemedicine Technology Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Diabetes Telemedicine Technology Product and Solutions
- 2.1.4 Medtronic Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Medtronic Recent Developments and Future Plans
- 2.2 Dexcom
- 2.2.1 Dexcom Details
- 2.2.2 Dexcom Major Business
- 2.2.3 Dexcom Diabetes Telemedicine Technology Product and Solutions
- 2.2.4 Dexcom Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Dexcom Recent Developments and Future Plans
- 2.3 Abbott Diabetes Care
- 2.3.1 Abbott Diabetes Care Details
- 2.3.2 Abbott Diabetes Care Major Business
- 2.3.3 Abbott Diabetes Care Diabetes Telemedicine Technology Product and Solutions
- 2.3.4 Abbott Diabetes Care Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Abbott Diabetes Care Recent Developments and Future Plans
- 2.4 Eli Lilly
- 2.4.1 Eli Lilly Details
- 2.4.2 Eli Lilly Major Business
- 2.4.3 Eli Lilly Diabetes Telemedicine Technology Product and Solutions
- 2.4.4 Eli Lilly Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Eli Lilly Recent Developments and Future Plans
- 2.5 Glooko
- 2.5.1 Glooko Details
- 2.5.2 Glooko Major Business
- 2.5.3 Glooko Diabetes Telemedicine Technology Product and Solutions
- 2.5.4 Glooko Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Glooko Recent Developments and Future Plans
- 2.6 Insulet
- 2.6.1 Insulet Details
- 2.6.2 Insulet Major Business
- 2.6.3 Insulet Diabetes Telemedicine Technology Product and Solutions
- 2.6.4 Insulet Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Insulet Recent Developments and Future Plans
- 2.7 Sanofi
- 2.7.1 Sanofi Details
- 2.7.2 Sanofi Major Business
- 2.7.3 Sanofi Diabetes Telemedicine Technology Product and Solutions
- 2.7.4 Sanofi Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Sanofi Recent Developments and Future Plans
- 2.8 Roche
- 2.8.1 Roche Details
- 2.8.2 Roche Major Business
- 2.8.3 Roche Diabetes Telemedicine Technology Product and Solutions
- 2.8.4 Roche Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Roche Recent Developments and Future Plans
- 2.9 9amHealth
- 2.9.1 9amHealth Details
- 2.9.2 9amHealth Major Business
- 2.9.3 9amHealth Diabetes Telemedicine Technology Product and Solutions
- 2.9.4 9amHealth Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 9amHealth Recent Developments and Future Plans
- 2.10 Philip
- 2.10.1 Philip Details
- 2.10.2 Philip Major Business
- 2.10.3 Philip Diabetes Telemedicine Technology Product and Solutions
- 2.10.4 Philip Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Philip Recent Developments and Future Plans
- 2.11 Eversense
- 2.11.1 Eversense Details
- 2.11.2 Eversense Major Business
- 2.11.3 Eversense Diabetes Telemedicine Technology Product and Solutions
- 2.11.4 Eversense Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Eversense Recent Developments and Future Plans
- 2.12 American Diabetes Association
- 2.12.1 American Diabetes Association Details
- 2.12.2 American Diabetes Association Major Business
- 2.12.3 American Diabetes Association Diabetes Telemedicine Technology Product and Solutions
- 2.12.4 American Diabetes Association Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 American Diabetes Association Recent Developments and Future Plans
- 2.13 ADCES
- 2.13.1 ADCES Details
- 2.13.2 ADCES Major Business
- 2.13.3 ADCES Diabetes Telemedicine Technology Product and Solutions
- 2.13.4 ADCES Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 ADCES Recent Developments and Future Plans
- 2.14 HealthPartners
- 2.14.1 HealthPartners Details
- 2.14.2 HealthPartners Major Business
- 2.14.3 HealthPartners Diabetes Telemedicine Technology Product and Solutions
- 2.14.4 HealthPartners Diabetes Telemedicine Technology Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 HealthPartners Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Diabetes Telemedicine Technology Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Diabetes Telemedicine Technology by Company Revenue
- 3.2.2 Top 3 Diabetes Telemedicine Technology Players Market Share in 2025
- 3.2.3 Top 6 Diabetes Telemedicine Technology Players Market Share in 2025
- 3.3 Diabetes Telemedicine Technology Market: Overall Company Footprint Analysis
- 3.3.1 Diabetes Telemedicine Technology Market: Region Footprint
- 3.3.2 Diabetes Telemedicine Technology Market: Company Product Type Footprint
- 3.3.3 Diabetes Telemedicine Technology Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Diabetes Telemedicine Technology Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Diabetes Telemedicine Technology Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Diabetes Telemedicine Technology Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Diabetes Telemedicine Technology Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Diabetes Telemedicine Technology Consumption Value by Type (2021-2032)
- 6.2 North America Diabetes Telemedicine Technology Market Size by Application (2021-2032)
- 6.3 North America Diabetes Telemedicine Technology Market Size by Country
- 6.3.1 North America Diabetes Telemedicine Technology Consumption Value by Country (2021-2032)
- 6.3.2 United States Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 6.3.3 Canada Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Diabetes Telemedicine Technology Consumption Value by Type (2021-2032)
- 7.2 Europe Diabetes Telemedicine Technology Consumption Value by Application (2021-2032)
- 7.3 Europe Diabetes Telemedicine Technology Market Size by Country
- 7.3.1 Europe Diabetes Telemedicine Technology Consumption Value by Country (2021-2032)
- 7.3.2 Germany Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 7.3.3 France Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 7.3.5 Russia Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 7.3.6 Italy Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Diabetes Telemedicine Technology Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Diabetes Telemedicine Technology Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Diabetes Telemedicine Technology Market Size by Region
- 8.3.1 Asia-Pacific Diabetes Telemedicine Technology Consumption Value by Region (2021-2032)
- 8.3.2 China Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 8.3.3 Japan Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 8.3.5 India Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 8.3.7 Australia Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Diabetes Telemedicine Technology Consumption Value by Type (2021-2032)
- 9.2 South America Diabetes Telemedicine Technology Consumption Value by Application (2021-2032)
- 9.3 South America Diabetes Telemedicine Technology Market Size by Country
- 9.3.1 South America Diabetes Telemedicine Technology Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Diabetes Telemedicine Technology Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Diabetes Telemedicine Technology Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Diabetes Telemedicine Technology Market Size by Country
- 10.3.1 Middle East & Africa Diabetes Telemedicine Technology Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
- 10.3.4 UAE Diabetes Telemedicine Technology Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Diabetes Telemedicine Technology Market Drivers
- 11.2 Diabetes Telemedicine Technology Market Restraints
- 11.3 Diabetes Telemedicine Technology Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Diabetes Telemedicine Technology Industry Chain
- 12.2 Diabetes Telemedicine Technology Upstream Analysis
- 12.3 Diabetes Telemedicine Technology Midstream Analysis
- 12.4 Diabetes Telemedicine Technology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Diabetes Telemedicine Technology. Industry analysis & Market Report on Diabetes Telemedicine Technology is a syndicated market report, published as Global Diabetes Telemedicine Technology Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Diabetes Telemedicine Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
